| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | inhibitory MHC class I receptor activity | 1.84e-04 | 12 | 34 | 2 | GO:0032396 | |
| GeneOntologyMolecularFunction | MHC class I receptor activity | 4.23e-04 | 18 | 34 | 2 | GO:0032393 | |
| GeneOntologyMolecularFunction | ribosome binding | 1.11e-03 | 120 | 34 | 3 | GO:0043022 | |
| GeneOntologyBiologicalProcess | multi-pass transmembrane protein insertion into ER membrane | 3.41e-07 | 9 | 34 | 3 | GO:0160063 | |
| GeneOntologyBiologicalProcess | intermediate filament organization | 6.88e-06 | 75 | 34 | 4 | GO:0045109 | |
| GeneOntologyBiologicalProcess | protein insertion into ER membrane | 1.78e-05 | 31 | 34 | 3 | GO:0045048 | |
| GeneOntologyBiologicalProcess | intermediate filament cytoskeleton organization | 2.07e-05 | 99 | 34 | 4 | GO:0045104 | |
| GeneOntologyBiologicalProcess | intermediate filament-based process | 2.16e-05 | 100 | 34 | 4 | GO:0045103 | |
| GeneOntologyBiologicalProcess | negative regulation of nodal signaling pathway | 5.51e-05 | 7 | 34 | 2 | GO:1900108 | |
| GeneOntologyBiologicalProcess | protein insertion into membrane | 7.61e-05 | 50 | 34 | 3 | GO:0051205 | |
| GeneOntologyBiologicalProcess | regulation of nodal signaling pathway | 9.43e-05 | 9 | 34 | 2 | GO:1900107 | |
| GeneOntologyBiologicalProcess | determination of left/right asymmetry in lateral mesoderm | 1.18e-04 | 10 | 34 | 2 | GO:0003140 | |
| GeneOntologyBiologicalProcess | keratinocyte differentiation | 2.55e-04 | 189 | 34 | 4 | GO:0030216 | |
| GeneOntologyBiologicalProcess | keratinization | 3.95e-04 | 87 | 34 | 3 | GO:0031424 | |
| GeneOntologyBiologicalProcess | epithelial cell-cell adhesion | 3.97e-04 | 18 | 34 | 2 | GO:0090136 | |
| GeneOntologyBiologicalProcess | lateral mesoderm development | 4.92e-04 | 20 | 34 | 2 | GO:0048368 | |
| GeneOntologyBiologicalProcess | negative regulation of activin receptor signaling pathway | 5.43e-04 | 21 | 34 | 2 | GO:0032926 | |
| GeneOntologyBiologicalProcess | endoplasmic reticulum organization | 7.23e-04 | 107 | 34 | 3 | GO:0007029 | |
| GeneOntologyBiologicalProcess | nodal signaling pathway | 8.36e-04 | 26 | 34 | 2 | GO:0038092 | |
| GeneOntologyBiologicalProcess | epidermis development | 8.89e-04 | 461 | 34 | 5 | GO:0008544 | |
| GeneOntologyBiologicalProcess | regulation of complement activation | 9.02e-04 | 27 | 34 | 2 | GO:0030449 | |
| GeneOntologyCellularComponent | multi-pass translocon complex | 3.59e-07 | 9 | 35 | 3 | GO:0160064 | |
| GeneOntologyCellularComponent | ER membrane insertion complex | 1.55e-06 | 14 | 35 | 3 | GO:0072379 | |
| GeneOntologyCellularComponent | intermediate filament | 3.60e-05 | 227 | 35 | 5 | GO:0005882 | |
| GeneOntologyCellularComponent | intermediate filament cytoskeleton | 7.23e-05 | 263 | 35 | 5 | GO:0045111 | |
| GeneOntologyCellularComponent | cornified envelope | 2.09e-04 | 69 | 35 | 3 | GO:0001533 | |
| HumanPheno | Demyelinating sensory neuropathy | 2.16e-06 | 2 | 8 | 2 | HP:0011402 | |
| Domain | DUF2012 | 2.20e-08 | 4 | 34 | 3 | PF09430 | |
| Domain | DUF2012 | 2.20e-08 | 4 | 34 | 3 | IPR019008 | |
| Domain | Carb-bd-like_fold | 3.07e-07 | 8 | 34 | 3 | IPR013784 | |
| Domain | CarboxyPept_regulatory_dom | 1.56e-06 | 13 | 34 | 3 | IPR014766 | |
| Domain | - | 1.56e-06 | 13 | 34 | 3 | 2.60.40.1120 | |
| Domain | CarboxyPept-like_regulatory | 3.68e-06 | 17 | 34 | 3 | IPR008969 | |
| Domain | A1B_glyco/leuk_Ig-like_rcpt | 4.80e-05 | 6 | 34 | 2 | IPR016332 | |
| Domain | Intermediate_filament_CS | 2.03e-04 | 63 | 34 | 3 | IPR018039 | |
| Domain | Filament | 2.89e-04 | 71 | 34 | 3 | SM01391 | |
| Domain | IF | 3.02e-04 | 72 | 34 | 3 | PS00226 | |
| Domain | Filament | 3.14e-04 | 73 | 34 | 3 | PF00038 | |
| Domain | IF | 3.54e-04 | 76 | 34 | 3 | IPR001664 | |
| Domain | Homeobox_metazoa | 5.81e-04 | 90 | 34 | 3 | IPR020479 | |
| Domain | Ig-like_fold | 1.55e-03 | 706 | 34 | 6 | IPR013783 | |
| Domain | Sushi | 4.03e-03 | 52 | 34 | 2 | PF00084 | |
| Domain | CCP | 4.34e-03 | 54 | 34 | 2 | SM00032 | |
| Domain | Homeobox_CS | 4.63e-03 | 186 | 34 | 3 | IPR017970 | |
| Domain | SUSHI | 4.66e-03 | 56 | 34 | 2 | PS50923 | |
| Domain | Sushi_SCR_CCP_dom | 4.82e-03 | 57 | 34 | 2 | IPR000436 | |
| Domain | ig | 4.92e-03 | 190 | 34 | 3 | PF00047 | |
| Domain | Immunoglobulin | 4.92e-03 | 190 | 34 | 3 | IPR013151 | |
| Domain | HTH_motif | 6.99e-03 | 69 | 34 | 2 | IPR000047 | |
| Domain | Prefoldin | 7.59e-03 | 72 | 34 | 2 | IPR009053 | |
| Domain | - | 8.00e-03 | 74 | 34 | 2 | 3.40.50.410 | |
| Domain | Homeobox | 8.73e-03 | 234 | 34 | 3 | PF00046 | |
| Domain | HOMEOBOX_1 | 8.93e-03 | 236 | 34 | 3 | PS00027 | |
| Domain | HOX | 9.03e-03 | 237 | 34 | 3 | SM00389 | |
| Domain | Homeobox_dom | 9.24e-03 | 239 | 34 | 3 | IPR001356 | |
| Domain | HOMEOBOX_2 | 9.24e-03 | 239 | 34 | 3 | PS50071 | |
| Domain | VWF_A | 1.40e-02 | 99 | 34 | 2 | IPR002035 | |
| Domain | - | 1.46e-02 | 283 | 34 | 3 | 1.10.10.60 | |
| Pathway | REACTOME_FORMATION_OF_THE_CORNIFIED_ENVELOPE | 3.68e-04 | 87 | 23 | 3 | MM15351 | |
| Pathway | REACTOME_KERATINIZATION | 3.84e-04 | 217 | 23 | 4 | M27640 | |
| Pathway | REACTOME_NEUTROPHIL_DEGRANULATION | 8.90e-04 | 478 | 23 | 5 | M27620 | |
| Pathway | REACTOME_FORMATION_OF_THE_CORNIFIED_ENVELOPE | 1.16e-03 | 129 | 23 | 3 | M27649 | |
| Pubmed | Silencing of nodal modulator 1 inhibits the differentiation of P19 cells into cardiomyocytes. | 9.34e-10 | 3 | 35 | 3 | 25576386 | |
| Pubmed | 9.34e-10 | 3 | 35 | 3 | 36011023 | ||
| Pubmed | Establishment of a conditional Nomo1 mouse model by CRISPR/Cas9 technology. | 3.73e-09 | 4 | 35 | 3 | 31833031 | |
| Pubmed | 3.73e-09 | 4 | 35 | 3 | 9267806 | ||
| Pubmed | The murine homeobox genes Nkx2.3 and Nkx2.6 are located on chromosomes 19 and 14, respectively. | 3.26e-08 | 7 | 35 | 3 | 8001981 | |
| Pubmed | Nicalin and its binding partner Nomo are novel Nodal signaling antagonists. | 5.21e-08 | 8 | 35 | 3 | 15257293 | |
| Pubmed | Substrate-driven assembly of a translocon for multipass membrane proteins. | 7.81e-08 | 9 | 35 | 3 | 36261522 | |
| Pubmed | An ER translocon for multi-pass membrane protein biogenesis. | 1.53e-07 | 11 | 35 | 3 | 32820719 | |
| Pubmed | 9.84e-07 | 2 | 35 | 2 | 19617579 | ||
| Pubmed | Distinct frequency patterns of LILRB3 and LILRA6 allelic variants in Europeans. | 9.84e-07 | 2 | 35 | 2 | 36449053 | |
| Pubmed | Characterization of LILRB3 and LILRA6 allelic variants in the Japanese population. | 9.84e-07 | 2 | 35 | 2 | 33526815 | |
| Pubmed | Immunoglobulin-like receptors and the generation of innate immune memory. | 9.84e-07 | 2 | 35 | 2 | 35034136 | |
| Pubmed | Diversity of the human LILRB3/A6 locus encoding a myeloid inhibitory and activating receptor pair. | 9.84e-07 | 2 | 35 | 2 | 24096970 | |
| Pubmed | 2.95e-06 | 3 | 35 | 2 | 9278324 | ||
| Pubmed | 2.95e-06 | 3 | 35 | 2 | 27892606 | ||
| Pubmed | Hepatic lipase maturation: a partial proteome of interacting factors. | 4.12e-06 | 31 | 35 | 3 | 19136429 | |
| Pubmed | 4.99e-06 | 33 | 35 | 3 | 30783098 | ||
| Pubmed | Protein-protein interactions between keratin polypeptides expressed in the yeast two-hybrid system. | 5.90e-06 | 4 | 35 | 2 | 9630597 | |
| Pubmed | 5.90e-06 | 4 | 35 | 2 | 9382880 | ||
| Pubmed | 6.07e-06 | 260 | 35 | 5 | 36199071 | ||
| Pubmed | 9.82e-06 | 5 | 35 | 2 | 12141427 | ||
| Pubmed | E3 Ligase Trim21 Ubiquitylates and Stabilizes Keratin 17 to Induce STAT3 Activation in Psoriasis. | 1.04e-05 | 135 | 35 | 4 | 29859926 | |
| Pubmed | 1.47e-05 | 6 | 35 | 2 | 9079806 | ||
| Pubmed | 2.06e-05 | 7 | 35 | 2 | 10603087 | ||
| Pubmed | Phenotypic characterization of the murine Nkx2.6 homeobox gene by gene targeting. | 2.06e-05 | 7 | 35 | 2 | 10733590 | |
| Pubmed | 2.06e-05 | 7 | 35 | 2 | 11002344 | ||
| Pubmed | 2.74e-05 | 8 | 35 | 2 | 9548455 | ||
| Pubmed | 2.74e-05 | 8 | 35 | 2 | 20424327 | ||
| Pubmed | 3.39e-05 | 62 | 35 | 3 | 26644517 | ||
| Pubmed | 3.53e-05 | 9 | 35 | 2 | 9344671 | ||
| Pubmed | 3.56e-05 | 63 | 35 | 3 | 31266804 | ||
| Pubmed | 5.38e-05 | 11 | 35 | 2 | 15469978 | ||
| Pubmed | PTPN14 regulates Roquin2 stability by tyrosine dephosphorylation. | 5.38e-05 | 678 | 35 | 6 | 30209976 | |
| Pubmed | Reactive-site-centric chemoproteomics identifies a distinct class of deubiquitinase enzymes. | 8.41e-05 | 84 | 35 | 3 | 29563501 | |
| Pubmed | PRDM14 directly interacts with heat shock proteins HSP90α and glucose-regulated protein 78. | 8.89e-05 | 14 | 35 | 2 | 29178343 | |
| Pubmed | Extensive gene duplications and a large inversion characterize the human leukocyte receptor cluster. | 8.89e-05 | 14 | 35 | 2 | 10941842 | |
| Pubmed | Periderm prevents pathological epithelial adhesions during embryogenesis. | 1.02e-04 | 15 | 35 | 2 | 25133425 | |
| Pubmed | The sequence and analysis of duplication-rich human chromosome 16. | 1.03e-04 | 90 | 35 | 3 | 15616553 | |
| Pubmed | TRIM25 and DEAD-Box RNA Helicase DDX3X Cooperate to Regulate RIG-I-Mediated Antiviral Immunity. | 1.07e-04 | 91 | 35 | 3 | 34445801 | |
| Pubmed | Genome duplications and other features in 12 Mb of DNA sequence from human chromosome 16p and 16q. | 1.10e-04 | 92 | 35 | 3 | 10493829 | |
| Pubmed | 1.17e-04 | 16 | 35 | 2 | 31823782 | ||
| Pubmed | 1.72e-04 | 107 | 35 | 3 | 32989256 | ||
| Pubmed | 1.87e-04 | 110 | 35 | 3 | 27889896 | ||
| Pubmed | 2.24e-04 | 22 | 35 | 2 | 37298108 | ||
| Pubmed | Multiplexed kinase interactome profiling quantifies cellular network activity and plasticity. | 2.68e-04 | 910 | 35 | 6 | 36736316 | |
| Pubmed | 2.91e-04 | 25 | 35 | 2 | 17388661 | ||
| Pubmed | A single-cell time-lapse of mouse prenatal development from gastrula to birth. | 2.91e-04 | 25 | 35 | 2 | 38355799 | |
| Pubmed | 3.51e-04 | 613 | 35 | 5 | 22268729 | ||
| Pubmed | LCP1 preferentially binds clasped αMβ2 integrin and attenuates leukocyte adhesion under flow. | 3.87e-04 | 344 | 35 | 4 | 30333137 | |
| Pubmed | 3.95e-04 | 346 | 35 | 4 | 25324306 | ||
| Pubmed | 4.30e-04 | 641 | 35 | 5 | 36057605 | ||
| Pubmed | DCAF8, a novel MuRF1 interaction partner, promotes muscle atrophy. | 4.78e-04 | 364 | 35 | 4 | 31391242 | |
| Pubmed | 4.79e-04 | 32 | 35 | 2 | 14973295 | ||
| Pubmed | WDFY4 is required for cross-presentation in response to viral and tumor antigens. | 5.21e-04 | 156 | 35 | 3 | 30409884 | |
| Pubmed | 5.70e-04 | 1049 | 35 | 6 | 27880917 | ||
| Pubmed | 6.41e-04 | 37 | 35 | 2 | 8076819 | ||
| Pubmed | LSD1 co-repressor Rcor2 orchestrates neurogenesis in the developing mouse brain. | 7.49e-04 | 40 | 35 | 2 | 26795843 | |
| Pubmed | 7.79e-04 | 731 | 35 | 5 | 29298432 | ||
| Pubmed | 8.53e-04 | 425 | 35 | 4 | 24999758 | ||
| Pubmed | 9.33e-04 | 1153 | 35 | 6 | 29845934 | ||
| Pubmed | 9.38e-04 | 191 | 35 | 3 | 33762435 | ||
| Interaction | LILRA6 interactions | 1.92e-08 | 4 | 35 | 3 | int:LILRA6 | |
| Cytoband | 19q13.4 | 3.08e-05 | 79 | 35 | 3 | 19q13.4 | |
| GeneFamily | CD molecules|Activating leukocyte immunoglobulin like receptors | 3.21e-05 | 6 | 27 | 2 | 1181 | |
| GeneFamily | NKL subclass homeoboxes and pseudogenes | 1.33e-04 | 67 | 27 | 3 | 519 | |
| GeneFamily | Hyalectan proteoglycans|V-set domain containing|Sushi domain containing|C-type lectin domain containing | 3.26e-03 | 57 | 27 | 2 | 1179 | |
| Coexpression | PASQUALUCCI_LYMPHOMA_BY_GC_STAGE_UP | 2.07e-06 | 297 | 34 | 6 | MM1003 | |
| ToppCell | COVID-19-Epithelial_cells-Airway_mucous|COVID-19 / group, cell type (main and fine annotations) | 5.89e-06 | 151 | 35 | 4 | 8216462e723fec2797387929dde095370947e10a | |
| ToppCell | droplet-Heart-HEART_(ALL_MINUS_AORTA)-30m-Myeloid-nan|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.36e-06 | 165 | 35 | 4 | 7f293f64e7df7710b13016937cdd4f1af326f8c3 | |
| ToppCell | COVID_vent-Lymphocytic-Plasma_cell-IgA_Plasmablast|COVID_vent / Disease condition, Lineage, Cell class and subclass | 1.68e-05 | 197 | 35 | 4 | 99fe44ef42c65d24fe64947fd5bf6d91b9a4b2c3 | |
| ToppCell | mild-Neutrophil|mild / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.75e-05 | 199 | 35 | 4 | 2fd5759acf49c02c5bbcc2941676216e7444d76d | |
| ToppCell | TCGA-Stomach-Primary_Tumor-Stomach_Adenocarcinoma-Stomach_Adenocarcinoma_-_Tubular-5|TCGA-Stomach / Sample_Type by Project: Shred V9 | 1.17e-04 | 121 | 35 | 3 | 392700c5032b83d4d4e191fea9bcd170e4567b9d | |
| ToppCell | Myeloid-Myeloid-E_(Neutrophils)|Myeloid / shred on cell class and cell subclass (v4) | 2.20e-04 | 150 | 35 | 3 | 1bffb8d86b737ac43be902d9468041aef3542f1f | |
| ToppCell | 10x_3'_v2v3-Neoplastic-Stem-like-NPC-like-NPC-like_OPC-D|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.47e-04 | 156 | 35 | 3 | 27590a4d2b419644966f0037c67c761fc275e0aa | |
| ToppCell | ICU-NoSEP-Lymphocyte-T_NK-dnT|ICU-NoSEP / Disease, Lineage and Cell Type | 2.51e-04 | 157 | 35 | 3 | c02500cf9255737c6229ec729803acd568485fb4 | |
| ToppCell | 368C-Myeloid-Macrophage-FABP4+_Macrophage_2|Macrophage / Donor, Lineage, Cell class and subclass (all cells) | 2.91e-04 | 165 | 35 | 3 | 3d2acdae0dd2b79a15f74158e8e566ce22b4218e | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c04-ANXA2|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.12e-04 | 169 | 35 | 3 | 01a24a8817628125bd004b2be68ffa62c7111f6e | |
| ToppCell | Monocytes-IFN-activated_Monocytes|World / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 3.23e-04 | 171 | 35 | 3 | df1b631618839bee4a18a2ba9c730321e5015f36 | |
| ToppCell | 343B-Lymphocytic-NK_cells-NK_cell_D3|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 3.40e-04 | 174 | 35 | 3 | e5f12831187140e84b9a49e93b2376b9fefb1aec | |
| ToppCell | 343B-Lymphocytic-NK_cells-NK_cell_D3|NK_cells / Donor, Lineage, Cell class and subclass (all cells) | 3.51e-04 | 176 | 35 | 3 | bd5c85b3a4fb88ffe156599f6d224aa7664a513a | |
| ToppCell | PCW_13-14-Neuronal-Neuronal_SCP|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 3.57e-04 | 177 | 35 | 3 | 621dd82f1393c961d4dd7a615aa52c9df9e36336 | |
| ToppCell | facs-Lung-3m-Hematologic-myeloid-myeloid_dendritic_cell-dendritic_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.63e-04 | 178 | 35 | 3 | 89f0537459a321ded956bf70ad56fefc0854f8b0 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L1-6_VIP_RGS16|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.69e-04 | 179 | 35 | 3 | ac94d4c32402c9b856fab656ac1aff0ee12d152c | |
| ToppCell | facs-Lung-EPCAM-3m-Myeloid-Dendritic_Cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.75e-04 | 180 | 35 | 3 | 710526abedc8e0f9ba19ad69220df4c9468ada8f | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L1-6_VIP_RGS16|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.81e-04 | 181 | 35 | 3 | 6c55985e464cb0f5fb3362e9fd90351b671950f7 | |
| ToppCell | 5'-Adult-LymphNode-Hematopoietic-Myeloid-Monocytes|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.87e-04 | 182 | 35 | 3 | 1fb9bdf2e9f0a9c230f109b471672f9c31e27c82 | |
| ToppCell | wk_15-18-Epithelial-PNS-SST+_neuron|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 3.87e-04 | 182 | 35 | 3 | a7e77aaaddabf78c7784f72b3431703fc5ee4a8c | |
| ToppCell | cellseq2-Immune-Hematopoietic-Granulocytic-Neutrophil|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.87e-04 | 182 | 35 | 3 | 1932d77491d6d46278f01fd70eb469ef1b356619 | |
| ToppCell | cellseq2-Immune-Hematopoietic-Granulocytic|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.94e-04 | 183 | 35 | 3 | cfbf8539104cef9ca830ad4f6bb278746f7078f7 | |
| ToppCell | cellseq2-Immune-Hematopoietic|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.94e-04 | 183 | 35 | 3 | 324ec4374b552da7ce03809945b3a0798342d4ba | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_C_(IT_L4_RORB)|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.00e-04 | 184 | 35 | 3 | 6475a43201b136dcc9b113d2ca4cfa154ed9d65d | |
| ToppCell | COVID_non-vent-Myeloid-Monocytic-Neutrophil|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 4.06e-04 | 185 | 35 | 3 | 2c89af7cdf5306b900a5b8ec4fdfb8210e5667ed | |
| ToppCell | severe_influenza-CD4+_Tcm|severe_influenza / disease group, cell group and cell class (v2) | 4.26e-04 | 188 | 35 | 3 | 633e5545f49b1b864b0ffa5fc9688d270690f884 | |
| ToppCell | COVID-19-Epithelial_cells-Tuft-like|COVID-19 / group, cell type (main and fine annotations) | 4.33e-04 | 189 | 35 | 3 | 2ffbe79fe3c3f22b1cb4269726b9eb5519be84a7 | |
| ToppCell | 10x_3'_v3-lymph_node_(10x_3'_v3)-myeloid-myeloid_granulocytic-neutrophil|lymph_node_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 4.33e-04 | 189 | 35 | 3 | 235c24eeab5139f5821fccd5c879d8787682f4ef | |
| ToppCell | wk_20-22-Hematologic-Myeloid-Neutrophil|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 4.39e-04 | 190 | 35 | 3 | 5da4a90f56f66567614d84b9b437f559006ea51c | |
| ToppCell | COPD-Endothelial-VE_Arterial|Endothelial / Disease state, Lineage and Cell class | 4.46e-04 | 191 | 35 | 3 | ef16ad1c1cd2c0c0377957398c98775b62a81754 | |
| ToppCell | Control-Plasmablast|Control / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 4.46e-04 | 191 | 35 | 3 | 3df5bbdb29bbcbcb8476fdf126b6d4c1ac67d64b | |
| ToppCell | 10x_3'_v3-tissue-resident_(10x_3'_v3)-myeloid-myeloid_granulocytic-neutrophil|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 4.46e-04 | 191 | 35 | 3 | b9b091d6b352d5128bb864ff52d2e5fb3387b766 | |
| ToppCell | 5'-Adult-LymphNode-Hematopoietic-Myeloid|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.46e-04 | 191 | 35 | 3 | 1e668d67bc254ea15518e2c7a029a61087609b7a | |
| ToppCell | mild-Lymphocytic-CD4_T_cells_2|Lymphocytic / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 4.53e-04 | 192 | 35 | 3 | 4cd8f572e067bf5fe22f62fa868d7d332f097a8c | |
| ToppCell | IPF-Endothelial-VE_Arterial|Endothelial / Disease state, Lineage and Cell class | 4.53e-04 | 192 | 35 | 3 | e911e286da26202853f9650ba3cdefe5a5c9b585 | |
| ToppCell | 10x_3'_v3-tissue-resident_(10x_3'_v3)-myeloid-myeloid_granulocytic|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 4.53e-04 | 192 | 35 | 3 | 3ce486cd5171f2d04ac4f7f87bead8b0d8c99c17 | |
| ToppCell | Control-Endothelial-VE_Arterial|Endothelial / Disease state, Lineage and Cell class | 4.53e-04 | 192 | 35 | 3 | 7e89b9125e8b85f6be85eeccef5c8644647ab0e1 | |
| ToppCell | URO|World / Disease, Lineage and Cell Type | 4.60e-04 | 193 | 35 | 3 | 421dc0996c6c973f88e90197b651255ae4dd13a2 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Myeloid-Macrophage-macrophage,_alveolar-Macro_c6-VCAN|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.60e-04 | 193 | 35 | 3 | 52f5b0fbb8ca706206c65e7edbb1ddbd380aebae | |
| ToppCell | Leuk-UTI|World / Disease, Lineage and Cell Type | 4.60e-04 | 193 | 35 | 3 | 26119a0b5d7684022fd16b8b73a0ef5a7d70f3d1 | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Hematopoietic-Myeloid-Monocytes|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.60e-04 | 193 | 35 | 3 | c0509798ce06da0ec725c0c7b5cc195455f2c29f | |
| ToppCell | droplet-Tongue-nan-3m-Epithelial-suprabasal|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.60e-04 | 193 | 35 | 3 | a7002acf3be76b2cc6fc9364176f6b0d3bd27d9c | |
| ToppCell | CTRL-Epithelial-Epithelial_cell|CTRL / Disease state, Lineage and Cell class | 4.67e-04 | 194 | 35 | 3 | 2bc4deaf2a01a39809fc323962fce4286835209c | |
| ToppCell | droplet-Tongue-nan-3m-Epithelial-keratinocyte|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.67e-04 | 194 | 35 | 3 | 592e8c4b73ba424a52305ac411ea9c0a2dc44467 | |
| ToppCell | COVID_vent-Myeloid-Monocytic-Neutrophil|COVID_vent / Disease condition, Lineage, Cell class and subclass | 4.67e-04 | 194 | 35 | 3 | eb23b171e429165dd26a64377eae7fa2ce25f547 | |
| ToppCell | 10x5'v1-week_17-19-Myeloid_neutrophil-granulo-neutrophil-neutrophil|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 4.67e-04 | 194 | 35 | 3 | e2d0dfb92356fa7ad7008aa8ac4198e2ac5d2495 | |
| ToppCell | CTRL-Epithelial|CTRL / Disease state, Lineage and Cell class | 4.67e-04 | 194 | 35 | 3 | 49dcb31427f370692308f939e23992925708abb7 | |
| ToppCell | control-Lymphocytic-CD4_T_cells_2|Lymphocytic / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 4.67e-04 | 194 | 35 | 3 | c2ae2ea848d78725455dcb6be9f1d8933745fa80 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Epithelial-TECs|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.74e-04 | 195 | 35 | 3 | 17c4d3b59cd0d79ce9ae5dde95586f3e923db16f | |
| ToppCell | 10x_3'_v3-lymph_node_(10x_3'_v3)-myeloid-myeloid_monocytic-classical_monocyte|lymph_node_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 4.74e-04 | 195 | 35 | 3 | 580ed65b4152483b642a7e7dbdf00d03588c46f6 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Epithelial-epithelial_cell_of_thymus|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.74e-04 | 195 | 35 | 3 | 66caa5c063184e7d3d653c8f6c289555cb36fa82 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Epithelial|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.74e-04 | 195 | 35 | 3 | ed74c113074fb5d3c42f2330b0e6042d32c3611a | |
| ToppCell | wk_15-18-Hematologic-Myeloid-Neutrophil|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 4.81e-04 | 196 | 35 | 3 | 36c01e0feea33448222010c21442b9fac671bd7d | |
| ToppCell | 10x_3'_v3-lymph_node_(10x_3'_v3)-myeloid-myeloid_monocytic|lymph_node_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 4.81e-04 | 196 | 35 | 3 | f943519bff51c3094776fd45889dadf9062c8379 | |
| ToppCell | 3'-Broncho-tracheal-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts-Peribronchial_fibroblasts_L.2.1.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.81e-04 | 196 | 35 | 3 | e7bfd4fb400ae0c473131d0fa306c26be08a6d03 | |
| ToppCell | 3'-Broncho-tracheal-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.81e-04 | 196 | 35 | 3 | 82fad623212d986a7fca3496faf3f8c8f5b83a11 | |
| ToppCell | 3'-Broncho-tracheal-Mesenchymal-Fibroblastic-fibroblastic_type_2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.81e-04 | 196 | 35 | 3 | 85e5046f774537684e1443c0fc147d562b7068d0 | |
| ToppCell | 10x5'v1-week_17-19-Myeloid_neutrophil-granulo-neutrophil|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 4.81e-04 | 196 | 35 | 3 | ad193b231ff2f7c72590fab79919c179d5d2f327 | |
| ToppCell | COVID_vent-Lymphocytic-Plasma_cell-IgM_Plasmablast|COVID_vent / Disease condition, Lineage, Cell class and subclass | 4.81e-04 | 196 | 35 | 3 | 026a06d8d2089806823e6f6453d3ede84ae93bc6 | |
| ToppCell | wk_15-18-Hematologic-Myeloid-S100A12-hi_cla._mono.|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 4.81e-04 | 196 | 35 | 3 | aa53ae1e5d08d31cfd81b7fae46c2b5d21d4f9b2 | |
| ToppCell | mild-Myeloid-Neutrophils_2|mild / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 4.81e-04 | 196 | 35 | 3 | e9f30eb8a3915c3b2af009c832bff9b349b65ae5 | |
| ToppCell | medial-2-Hematologic-Classical_Monocyte|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 4.88e-04 | 197 | 35 | 3 | fbff79d6ece1605126ae0caa0c71253ea557779c | |
| ToppCell | medial-Hematologic-Classical_Monocyte|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 4.88e-04 | 197 | 35 | 3 | 3960eac4b6753e3294e13901f6ea13d894275c8d | |
| ToppCell | COVID-19_Moderate-Classical_Monocyte|COVID-19_Moderate / disease group, cell group and cell class | 4.88e-04 | 197 | 35 | 3 | 98d4107e457e7399a84439acd73bf8f59598971b | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-Mono-Mono_naive|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 4.88e-04 | 197 | 35 | 3 | e5a1e846bbfec234cb50c87c1f24beb43fce6856 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_epithelium-respiratory_basal_cell-Suprabasal-Suprabasal_L.0.0.1.3|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.88e-04 | 197 | 35 | 3 | 233b9fcb376e08d0080a05ca0198ecc6ec720f90 | |
| ToppCell | severe-Lymphocytic-CD4_T_cells_2|Lymphocytic / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 4.88e-04 | 197 | 35 | 3 | 3b71e523d8a68f131def17233385df371db70db5 | |
| ToppCell | 10x_3'_v3-thymus_(10x_3'_v3)-myeloid-myeloid_monocytic|thymus_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 4.88e-04 | 197 | 35 | 3 | b91016249b3585aa3536e96af18e4f1b1d2d5ce4 | |
| ToppCell | wk_20-22-Hematologic-Myeloid-S100A12-hi_cla._mono.|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 4.88e-04 | 197 | 35 | 3 | e862561f61a1ae1ec858b34f8d9c9a7dc8894104 | |
| ToppCell | 10x5'v1-week_12-13-Myeloid_neutrophil-granulo-neutrophil-neutrophil|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 4.88e-04 | 197 | 35 | 3 | 8dd10962b6ba587512b2e68c762ade68c751cbc8 | |
| ToppCell | 10x_3'_v3-thymus_(10x_3'_v3)-myeloid-myeloid_monocytic-monocyte|thymus_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 4.88e-04 | 197 | 35 | 3 | ec46aa307ce5774b4c0fcba64514f2d0cab3c4f9 | |
| ToppCell | 10x_3'_v3-blood_(10x_3'_v3)|10x_3'_v3 / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 4.88e-04 | 197 | 35 | 3 | 2d3547107c88c7443fc6425742694e13368a71f5 | |
| ToppCell | COVID-19_Severe-Classical_Monocyte|World / disease group, cell group and cell class | 4.88e-04 | 197 | 35 | 3 | 344801997b89bd81d8d5c3c872934de523233a8d | |
| ToppCell | distal-1-Epithelial-Basal|1 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 4.88e-04 | 197 | 35 | 3 | 25a2ccc98b973611de0d920b1b455d0b40f0d37f | |
| ToppCell | COVID_non-vent-Lymphocytic-Plasma_cell|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 4.88e-04 | 197 | 35 | 3 | 1e63879633f20646e44873ae6b662f6faf4806fd | |
| ToppCell | medial-Hematologic-Classical_Monocyte-2|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 4.88e-04 | 197 | 35 | 3 | ae2b51d4e91126ee0a0f69c040297c2a78ce27dd | |
| ToppCell | severe-Others-Megakaryocytes|Others / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 4.88e-04 | 197 | 35 | 3 | fc0864e2de2d9f99084586b467551b6da535d933 | |
| ToppCell | distal-Epithelial-Basal-1|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 4.88e-04 | 197 | 35 | 3 | 75b4292ce2ad7f9c8b6a4781e1cb71f5b18b74e3 | |
| ToppCell | saliva-Severe-critical_progression_d12-22_no-steroids-Epithelial-Epithelial,_Airway-squamous_epithelial_cell-Epi-Squamous|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.95e-04 | 198 | 35 | 3 | 72d91bd0c727ecadc41e023a16c9326158db1b7b | |
| ToppCell | severe-Myeloid|severe / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 4.95e-04 | 198 | 35 | 3 | d19902a6353445f9875dec59933b7553f5145b8b | |
| ToppCell | NS-critical-d_0-4-Myeloid|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 4.95e-04 | 198 | 35 | 3 | 72d51284d267f102c26f0ae8279ee9e11e69c7e3 | |
| ToppCell | saliva-Severe-critical_progression_d12-22_no-steroids-Epithelial|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.95e-04 | 198 | 35 | 3 | fb3965049cb1961de0d2e74370868e46aa5050c8 | |
| ToppCell | saliva-Severe-critical_progression_d12-22_no-steroids-Epithelial-Epithelial,_Airway-squamous_epithelial_cell|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.95e-04 | 198 | 35 | 3 | 441608034c787e55691558a480dcd07e37419138 | |
| ToppCell | cellseq2-Immune-Immune_Myeloid-iMON-iMON|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 4.95e-04 | 198 | 35 | 3 | a6aa113f0af4d25c032f440c3134fe4d88ca5055 | |
| ToppCell | cellseq2-Immune-Immune_Myeloid-iMON|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 4.95e-04 | 198 | 35 | 3 | a0ceed8689d42be6b9cde89d6c182d10b3fb14fc | |
| ToppCell | saliva-Severe-critical_progression_d12-22_no-steroids-Epithelial-Epithelial,_Airway|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.95e-04 | 198 | 35 | 3 | 9f5726aedd1fb132feab717a029fa302306461b5 | |
| ToppCell | Parenchymal-10x5prime-Stromal-Fibroblastic-Fibro_peribronchial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 4.95e-04 | 198 | 35 | 3 | 300d7cc56207d77168390fa1ffcbcf76767b1b80 | |
| ToppCell | mild-Myeloid|mild / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 4.95e-04 | 198 | 35 | 3 | 908746384e10c6b833bb3bc124045d7b0bfd73b5 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-Mono|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 5.03e-04 | 199 | 35 | 3 | 87956fcb39c2e3e99622ff05f99267d7621a78fc | |
| ToppCell | PBMC-Mild-Myeloid-Classical_Monocyte-Classical_Monocyte-cMono_3|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 5.03e-04 | 199 | 35 | 3 | 9314eb9a89407738626a0384884454b5f9031ee7 | |
| ToppCell | severe-Myeloid-Neutrophils_4|Myeloid / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 5.03e-04 | 199 | 35 | 3 | 50242666def13e5d4149c563ae000d6768f086f7 | |
| ToppCell | wk_20-22-Hematologic-Myeloid|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 5.03e-04 | 199 | 35 | 3 | 0740166c51ce63edf83c4b98fce057f1440116d7 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_epithelium-respiratory_basal_cell-Suprabasal-Suprabasal_L.0.0.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.03e-04 | 199 | 35 | 3 | c88a28a73f54dc571f2ff1e4b55073f83cbead2c | |
| ToppCell | 10x3'2.3-week_14-16-Myeloid_neutrophil-granulo-neutrophil-neutrophil|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 5.03e-04 | 199 | 35 | 3 | 0dde17381b8a95bfddb4d1052b13d33f37b05d13 | |
| ToppCell | TCGA-Cervix-Primary_Tumor|TCGA-Cervix / Sample_Type by Project: Shred V9 | 5.03e-04 | 199 | 35 | 3 | ef6fde26af2ca9e6cde198ac0e14e03d9ab398f8 | |
| ToppCell | Sepsis-ICU-NoSEP-Lymphocyte-T/NK-dn_T|ICU-NoSEP / Disease, condition lineage and cell class | 5.03e-04 | 199 | 35 | 3 | 7fb211f803a8b3a2cfa9455386abea08131c6b52 | |
| ToppCell | PBMC-Mild-Myeloid-Classical_Monocyte-Classical_Monocyte-cMono_3|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 5.03e-04 | 199 | 35 | 3 | dbf0bf09896c46155ae6fbd6307f097799e7e34e | |
| ToppCell | distal-1-Epithelial-Proliferating_Basal|1 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 5.03e-04 | 199 | 35 | 3 | 93450257180d918c310bca7b5defc74390c48091 | |
| ToppCell | mild-Neutrophil|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 5.03e-04 | 199 | 35 | 3 | ca319976a7d2576186d0a98cdc93e4c2d5fe8a05 | |
| ToppCell | 10x5'v1-week_12-13-Myeloid_monocytic-monocyte-CD14_monocyte|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 5.10e-04 | 200 | 35 | 3 | 62e9ca7cf4f49fc8957740acee41a1e530f10541 | |
| Computational | Keratin. | 1.39e-05 | 26 | 20 | 3 | MODULE_298 | |
| Computational | Genes in the cancer module 68. | 1.39e-05 | 26 | 20 | 3 | MODULE_68 | |
| Computational | Neighborhood of CD1D | 7.44e-05 | 45 | 20 | 3 | GNF2_CD1D | |
| Computational | Neighborhood of CD33 | 1.15e-04 | 52 | 20 | 3 | GNF2_CD33 | |
| Computational | Neighborhood of TNFRSF1B | 2.24e-04 | 65 | 20 | 3 | GNF2_TNFRSF1B | |
| Computational | Intermediate filaments and MT. | 2.56e-04 | 68 | 20 | 3 | MODULE_438 | |
| Computational | Neighborhood of CARD15 | 2.79e-04 | 70 | 20 | 3 | GNF2_CARD15 | |
| Computational | Neighborhood of HCK | 6.63e-04 | 94 | 20 | 3 | GNF2_HCK | |
| Computational | Genes in the cancer module 153. | 1.78e-03 | 34 | 20 | 2 | MODULE_153 | |
| Computational | Neighborhood of CD14 | 1.89e-03 | 35 | 20 | 2 | GNF2_CD14 | |
| Computational | Genes in the cancer module 533. | 3.10e-03 | 45 | 20 | 2 | MODULE_533 | |
| Drug | alpha-bromo-4-chlorophenylacetic acid | 6.49e-06 | 3 | 34 | 2 | CID010490868 | |
| Drug | l-945 | 6.49e-06 | 3 | 34 | 2 | CID000097919 | |
| Drug | cupric acetate monohydrate | 2.16e-05 | 5 | 34 | 2 | CID000165397 | |
| Drug | DBTA | 3.23e-05 | 6 | 34 | 2 | CID000149053 | |
| Drug | norfluoxetine | 4.72e-05 | 47 | 34 | 3 | CID000004541 | |
| Drug | RAWVAWRNR | 7.74e-05 | 9 | 34 | 2 | CID000460901 | |
| Drug | O-demethylmetoprolol | 7.74e-05 | 9 | 34 | 2 | CID000162181 | |
| Drug | 2-bromopropionate | 7.74e-05 | 9 | 34 | 2 | CID000011729 | |
| Disease | leukocyte immunoglobulin-like receptor subfamily A member 6 measurement | 1.70e-05 | 6 | 32 | 2 | EFO_0801767 | |
| Disease | leukocyte immunoglobulin-like receptor subfamily B member 3 measurement | 1.70e-05 | 6 | 32 | 2 | EFO_0802705 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| LSFSYCGTYLASYSS | 116 | Q8NDM7 | |
| TYSSAGDSVYTYFSA | 46 | P28676 | |
| HCLATTYGSSYFSGS | 411 | Q8IV13 | |
| GYTAAYTSYAPYGTS | 111 | Q07687 | |
| AAVSPYSCYGGYSGA | 236 | A6NCS4 | |
| GYRTAYSCYGTVSSL | 956 | P69849 | |
| GYRTAYSCYGTVSSL | 956 | Q5JPE7 | |
| YSCGSTYYADSVKGR | 71 | A0A0C4DH42 | |
| SCYSSSCYSTSCYSS | 681 | Q76N89 | |
| SCYSTSCYSSSCYSA | 686 | Q76N89 | |
| SCYSSSCYSASCYSP | 691 | Q76N89 | |
| CTTFSTTSGYMEGYY | 366 | Q9UK99 | |
| GSGSSYSYSRGHYES | 326 | Q86YZ3 | |
| GYRTAYSCYGTVSSL | 956 | Q15155 | |
| VTSAHAGTYRCYGSY | 386 | Q6PI73 | |
| AGTYRCYGSYSSNPH | 391 | Q6PI73 | |
| VTSAHAGTYRCYGSY | 386 | O75022 | |
| AGTYRCYGSYSSNPH | 391 | O75022 | |
| TLGGSSYSSCYSFGS | 51 | Q04695 | |
| DATGNSSYSYSYSFS | 2851 | P15924 | |
| FYSASAIYGGSASYS | 566 | Q9BY84 | |
| AIYGGSASYSAYSCS | 571 | Q9BY84 | |
| CNIFSYDYSGYGVSS | 161 | Q6PCB6 | |
| CYDGYESSYGNTTDS | 176 | Q92496 | |
| NASFTYGYEYLGCTS | 1121 | Q0VDD8 | |
| SSHSCEGYLCYSGYS | 11 | A1A580 | |
| AAAAAAYSSSYGCAY | 281 | Q8TAU0 | |
| YGGQYTCSGAYNLSS | 291 | Q8N6C8 | |
| PFASASSSVYYGSYS | 91 | Q8N5F7 | |
| SSSVYYGSYSRPYGS | 96 | Q8N5F7 | |
| YASDGATYGSSSGLC | 196 | Q9UN30 | |
| SLGCISRYSAGSVYY | 701 | O95486 | |
| GGSHYSSSGYSNSRY | 186 | Q9BRL6 | |
| LTYLSTASYSCDTGY | 1921 | Q4LDE5 | |
| DYYTRACDGGYTSSC | 136 | Q96BR5 | |
| YLDGYCPSGSSLTYS | 161 | Q68D42 | |
| YTYSSCGKGCNYSSL | 286 | Q9UJU3 | |
| TAVTYSGTSYSGYEA | 256 | Q96KR1 | |
| SGTSYSGYEAAVYSA | 261 | Q96KR1 | |
| SSGYSSNYAYAPSSL | 146 | Q9Y5A9 | |
| GFGASSSYSYKTAAA | 466 | Q14CN4 | |
| SGYSTARSAYSSYSA | 31 | P07196 |